StockData
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc. (RNA) stock

RNANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$6.64+0.16 (+2.47%)

Close on Nov 18, 2026Market cap $113.58MP/E –Yield –

Atrium Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Atrium Therapeutics's market cap was $136.16M on Nov 11, 2026.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$136.16M–

More Atrium Therapeutics figures

See a number that looks wrong?